At the recent ISIRV OptionsX conference in Singapore, the Gates foundation announced Grand Challenges Grantees for their Universal Influenza Vaccine Development call. This included The … Read more
Chair and invited talk on bat influenza H17N10 at Emerging Viruses 2019 (Oxford, 9th Sept 2019)
On 9th Sept 2019 I am co-chairing a symposium on Emerging Viruses with Dr Wright (Sussex) and Dr Scott (Kent). During this symposium I will … Read more
Visit to the University of Siena
Today I visited the University of Siena, Italy. It is one of the oldest universities in Italy, established in 1240. The university now offers a … Read more
Nigel Temperton’s research on influenza pseudotypes profiled in Microbiology Today
My research on pseudotyping influenza HA and NA onto lentiviral cores has been profiled in the Microbiology Society magazine, Microbiology today. You can read the … Read more
Influenza 2018: Centenary of the 1918 Pandemic
I am currently attending the Centenary of the 1918 influenza pandemic meeting at the wonderful Crick institute. There are delegates from over 40 countries here … Read more
Invited talk at Nanotechnology for Healthcare: Progress in Recombinant Vaccines, Molecular Adjuvants and Modern Drug Delivery Systems
I was invited to give a talk at the 11th International Conference “Nanotechnology for Healthcare: Progress in Recombinant Vaccines, Molecular Adjuvants and Modern Drug Delivery Systems” … Read more
Offered paper at Microbiology Society 2018 Annual Conference, Birmingham 12th April 2018
Talk delivered in the Clinical Virology workshop Offered paper: Utilisation of chimeric haemagglutinin bearing lentiviral pseudotypes to dissect head and stalk directed antibody responses Nigel … Read more
VPU Temperton lab PhD student George Carnell gets PhD on influenza immunity
George Carnell has today received notification that his PhD corrections from his viva have been accepted. His external PhD examiner was Prof. Ian Jones from Reading … Read more
Temperton lab embracing Pre-print culture at bioRxiv
The Temperton lab has embraced the pre-print revolution. Please find our bioRxiv pre-prints here.
Nigel Temperton is now a member of the HIC-Vac network
HIC-Vac is an international network of researchers who are developing human infection challenge (HIC) studies to accelerate the development of vaccines against pathogens of high … Read more